HERACLES
23 Jun 26
Development of a complex secretome-based biological product for the regeneration of acute muscle injuries Abstract: The HERACLES project aims to
Development of a complex secretome-based biological product for the regeneration of acute muscle injuries Abstract: The HERACLES project aims to
Development of new prevention and diagnostic tools for antibiotic-resistant Klebsiella pneumoniae infections Abstract: The project aims to advance the clinical development
Leitat, Ona Therapeutics and IRB Barcelona Collaborate to Develop a New Therapy for Colorectal Cancer The objective of the ADC-CRC
Recently, the PREDICTFTD consortium gathered in Desenzano del Garda (Italy) for a two-day meeting hosted by the University of Verona.
Tthe VaMPIRE consortium gathered in Barcelona for a two-day meeting hosted by the project coordinator, Linkcare Health Services, on 23-24th
Oncomatryx, partner and coordinator of the NEXTOM project, visited Leitat’s facilities at the Parc Científic de Barcelona (PCB) for an
The DiMεD project has enabled progress in technologies for surgical implants adapted to each patient through the research of new
Recently, the TEN4CARE consortium gathered in Bilbao for its 6-Month General Assembly. Two intense and highly productive days of co-creation,
Bio-based Polymers for New Sustainable Water-Soluble Sheets Abstract: The BIOWASHEETS project aims to innovate in the fast-moving consumer goods (FMCG)
Preclinical Discovery and Development of New Compounds as HPK1 Inhibitors for Cancer Treatment Abstract: The overall objective of the project
FERTIL IBERICA SL is driving a project for the design and manufacture of an innovative microfluidic chip aimed at more
Monitoring of Urinary Biomarkers in Bathrooms for the Non-Invasive Evaluation of Athlete Health and Performance Abstract: The OLYMPIA project aims
Recently, the Leitat Terrassa facilities hosted the consortium meeting of the GUTBABI project, a PCPP 2023, where project partners gathered
Last week, the partners of the APPEAL project gathered in person for the second time, marking a major milestone in
Leitat successfully concluded its participation in MEDICA 2025, the world’s leading trade fair for medical technology, held from November 17
The certification, granted by AENOR, consolidates the organisation as a key player in healthcare innovation in Spain, guaranteeing the highest